Source: Clinical Biotechnology. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAGAI, Maria Aparecida et al. C-erb b-2 dna amplification and mrna expression in human primary breast tumors and its relationship to other prognostic factors. Clinical Biotechnology, v. 4 , n. 1 , p. 21-4, 1992Tradução . . Acesso em: 03 nov. 2024.APA
Nagai, M. A., Pacheco, M. M., Oshima, C. T. F., & Brentani, M. M. (1992). C-erb b-2 dna amplification and mrna expression in human primary breast tumors and its relationship to other prognostic factors. Clinical Biotechnology, 4 ( 1 ), 21-4.NLM
Nagai MA, Pacheco MM, Oshima CTF, Brentani MM. C-erb b-2 dna amplification and mrna expression in human primary breast tumors and its relationship to other prognostic factors. Clinical Biotechnology. 1992 ;4 ( 1 ): 21-4.[citado 2024 nov. 03 ]Vancouver
Nagai MA, Pacheco MM, Oshima CTF, Brentani MM. C-erb b-2 dna amplification and mrna expression in human primary breast tumors and its relationship to other prognostic factors. Clinical Biotechnology. 1992 ;4 ( 1 ): 21-4.[citado 2024 nov. 03 ]
